Peri-operative measures for treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage

Neurological Research

Volumn 31, Issue 6, 2009, Pages 651-659

  Alaraj, Ali ^a   Charbel, Fady T ^a   Amin Hanjani, Sepideh ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Aneurysm; Clipping; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ASCORBIC ACID; NICARDIPINE; PAPAVERINE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VERAPAMIL;

ANESTHESIA; ANEURYSM RUPTURE; ANEURYSM SURGERY; BLOOD CLOTTING; BLOOD PRESSURE MONITORING; BRAIN VASOSPASM; CEREBROSPINAL FLUID DRAINAGE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; FENESTRATION; HUMAN; HYPERTENSION; HYPOTENSION; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIOPERATIVE PERIOD; REVIEW; SUBARACHNOID HEMORRHAGE; SURGICAL RISK; SURGICAL TECHNIQUE; TACHYCARDIA; TREATMENT OUTCOME;

ANEURYSM, RUPTURED; CEREBRAL ANGIOGRAPHY; CLINICAL PROTOCOLS; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PREOPERATIVE CARE; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, X-RAY COMPUTED; VASOSPASM, INTRACRANIAL;

EID: 68149183517     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313209X382395     Document Type: Review

References (57)

1. Kassell NF, Torner JC, Haley EC, Jr, et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 1990; 73 (1): 18-36 (Pubitemid 20206379)
2. Haley EC, Jr, Kassell NF, Torner JC. The International Cooperative Study on the Timing of Aneurysm Surgery. The North American experience. Stroke 1992; 23 (2): 205-214
3. Kistler JP, Crowell RM, Davis KR, et al. The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: A prospective study. Neurology 1983; 33 (4): 424-436
4. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6 (1): 1-9
5. Kassell NF, Sasaki T, Colohan AR, et al. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985; 16 (4): 562-572 (Pubitemid 15007226)
6. Biller J, Godersky JC, Adams HP, Jr. Management of aneurysmal subarachnoid hemorrhage. Stroke 1988; 19 (10): 1300-1305
7. Hijdra A, van Gijn J, Stefanko S, et al. Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: Clinicoanatomic correlations. Neurology 1986; 36 (3): 329-333 (Pubitemid 16125148)
8. Treggiari-Venzi MM, Suter PM, Romand JA. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: A problem of neurointensive care. Neurosurgery 2001; 48 (2): 249-261
9. Rabinstein AA, Pichelmann MA, Friedman JA, et al. Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: A comparison between surgical repair and endovascular coil occlusion. J Neurosurg 2003; 98 (2): 319-325
10. Dehdashti AR, Mermillod B, Rufenacht DA, et al. Does treatment modality of intracranial ruptured aneurysms influence the incidence of cerebral vasospasm and clinical outcome? Cerebrovasc Dis 2004; 17 (1): 53-60
11. Goddard AJ, Raju PP, Gholkar A. Does the method of treatment of acutely ruptured intracranial aneurysms influence the incidence and duration of cerebral vasospasm and clinical outcome? J Neurol Neurosurg Psychiatry 2004; 75 (6): 868-872
12. Hoh BL, Topcuoglu MA, Singhal AB, et al. Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery 2004; 55 (4): 779-786
13. Maurice-Williams RS, Wadley JP. Delayed surgery for ruptured intracranial aneurysms: a reappraisal. Br J Neurosurg 1997; 11 (2): 104-109 (Pubitemid 27187205)
14. Saito I, Ueda Y, Sano K. Significance of vasospasm in the treatment of ruptured intracranial aneurysms. J Neurosurg 1977; 47 (3): 412-429 (Pubitemid 8170130)
15. Findlay JM, Macdonald RL, Weir BK, et al. Surgical manipulation of primate cerebral arteries in established vasospasm. J Neurosurg 1991; 75 (3): 425-432
16. Macdonald RL, Wallace MC, Coyne TJ. The effect of surgery on the severity of vasospasm. J Neurosurg 1994; 80 (3): 433-439
17. Solomon RA, Onesti ST, Klebanoff L. Relationship between the timing of aneurysm surgery and the development of delayed cerebral ischemia. J Neurosurg 1991; 75 (1): 56-61
18. McLaughlin N, Bojanowski MW. Aneurysmal surgery in the presence of angiographic vasospasm: An outcome assessment. Can J Neurol Sci 2006; 33 (2): 181-188 (Pubitemid 43845171)
19. de Gans K, Nieuwkamp DJ, Rinkel GJ, et al. Timing of aneurysm surgery in subarachnoid hemorrhage: A systematic review of the literature. Neurosurgery 2002; 50 (2): 336-340 (Pubitemid 41672589)
20. Tabuchi S, Hirano N, Tanabe M, et al. Relationship of hypotension and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Neurol Res 2006; 28 (2): 196-199
21. Han RQ, Li SR, Wang BG, et al. [The effect of isoflurane induced hypotension on intraoperative cerebral vasospasm in intracranial aneurysm surgery]. Zhonghua Yi Xue Za Zhi 2004; 84 (4): 286-289
22. Liu HM, Tu YK. The efficacy of papaverine administration by different routes for the treatment of experimental acute cerebral vasospasm. J Clin Neurosci 2002; 9 (5): 561-565
23. Segawa H, Saito I, Okada T, et al. [Efficacy of intracisternal papaverine on symptomatic vasospasm]. No Shinkei Geka 1986; 14 (7): 847-854
24. Volllmer D, Jane J, Torner J. Papaverine reverses experimental vasospasm in a rabbit model. In: Wilkins R, ed. Cerebral Vasospasm, New York: Raven Press, 1988: pp. 425-432
25. Shiokawa K, Kasuya H, Miyajima M, et al. Prophylactic effect of papaverine prolonged-release pellets on cerebral vasospasm in dogs. Neurosurgery 1998; 42 (1): 109-115 (Pubitemid 28067032)
26. Baldwin ME, Macdonald RL, Huo D, et al. Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome. Stroke 2004; 35 (11): 2506-2511 (Pubitemid 39458408)
27. Reilly C, Amidei C, Tolentino J, et al. Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 2004; 101 (2): 255-261 (Pubitemid 38971001)
28. Tsuruno T. [Intraoperative radical clot removal therapy using a bipolar irrigation system for prevention of cerebral vasospasm following subarachnoid hemorrhage]. No Shinkei Geka 2005; 33 (4): 343-348
29. Findlay JM, Deagle GM. Causes of morbidity and mortality following intracranial aneurysm rupture. Can J Neurol Sci 1998; 25 (3): 209-215 (Pubitemid 28368796)
30. Findlay JM, Macdonald RL, Weir BK. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev 1991; 3 (4): 336-361
31. Kinouchi H, Ogasawara K, Shimizu H, et al. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage. Neurol Med Chir (Tokyo) 2004; 44 (11): 569-575 (Pubitemid 39612171)
32. Mizoi K, Yoshimoto T, Takahashi A, et al. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg 1993; 78 (3): 430-437 (Pubitemid 23073213)
33. Usui M, Saito N, Hoya K, et al. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: A retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Neurosurgery 1994; 34 (2): 235-244 (Pubitemid 24044100)
34. Seifert V, Stolke D, Zimmermann M, et al. Prevention of delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage by intrathecal bolus injection of tissue plasminogen activator (rTPA). A prospective study. Acta Neurochir (Wien) 1994; 128 (1-4): 137-143
35. Moriyama E, Matsumoto Y, Meguro T, et al. Combined cisternal drainage and intrathecal urokinase injection therapy for prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 1995; 35 (10): 732-736
36. Majchrzak H, Lech A, Kopera M, et al. [Application of alteplase in prevention of cerebral vasospasm and its sequelae in patients after aneurysmal subarachnoid hemorrhage from ruptured cerebral aneurysm]. Neurol Neurochir Pol 1995; 29 (3): 379-387
37. Findlay JM, Kassell NF, Weir BK, et al. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 1995; 37 (1): 168-176
38. Gorski R, Zabek M, Jarmuzek P. Influence of intraoperative using of recombinant tissue plasminogen activator on the development of cerebral angiospasm after subarachnoid haemorrhage in patients with ruptured intracranial aneurysms. Neurol Neurochir Pol 2000; 34 (Suppl. 6): S41-S47
39. Amin-Hanjani S, Ogilvy CS, Barker FG, 2nd. Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery 2004; 54 (2): 326-334
40. Ohmoto T, Yoshioka J, Shibata K, et al. Cerebral vasospasm following subarachnoid hemorrhage - experimental and clinical studies. Neurol Med Chir (Tokyo) 1979; 19 (1): 73-81 (Pubitemid 9118322)
41. Konno Y, Sato T, Suzuki K, et al. Sequential changes of oxyhemoglobin in drained fluid of cisternal irrigation therapy - reference to the effect of ascorbic acid. Acta Neurochir Suppl 2001; 77: 167-169 (Pubitemid 33759240)
42. Kodama N, Sasaki T, Kawakami M, et al. Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients. Surg Neurol 2000; 53 (2): 110-117 (Pubitemid 30122315)
43. Andaluz N, Zuccarello M. Fenestration of the lamina terminalis as a valuable adjunct in aneurysm surgery. Neurosurgery 2004; 55 (5): 1050-1059 (Pubitemid 39525195)
44. Kasuya H, Onda H, Sasahara A, et al. Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 2005; 56 (5): 895-902 (Pubitemid 40628076)
45. Barth M, Capelle HH, Weidauer S, et al. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: A prospective, randomized, double-blind phase IIa study. Stroke 2007; 38 (2): 330-336 (Pubitemid 46188258)
46. Kasuya H, Onda H, Takeshita M, et al. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke 2002; 33 (4): 1011-1015 (Pubitemid 34293584)
47. Dalbasti T, Karabiyikoglu M, Ozdamar N, et al. Efficacy of controlled-release papaverine pellets in preventing symptomatic cerebral vasospasm. J Neurosurg 2001; 95 (1): 44-50 (Pubitemid 32799771)
48. Firlik KS, Firlik AD, Yonas H. Xenon-enhanced computed tomography in the management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Keio J Med 2000; 49 (Suppl. 1): A148-A150 (Pubitemid 30210269)
49. Firlik AD, Kaufmann AM, Jungreis CA, et al. Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1997; 86 (5): 830-839
50. Yonas H, Sekhar L, Johnson DW, et al. Determination of irreversible ischemia by xenon-enhanced computed tomographic monitoring of cerebral blood flow in patients with symptomatic vasospasm. Neurosurgery 1989; 24 (3): 368-372 (Pubitemid 19090392)
51. Lewis DH, Eskridge JM, Newell DW, et al. Brain SPECT and the effect of cerebral angioplasty in delayed ischemia due to vasospasm. J Nucl Med 1992; 33 (10): 1789-1796
52. Hoh BL, Ogilvy CS. Endovascular treatment of cerebral vasospasm: Transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine. Neurosurg Clin N Am 2005; 16 (3): 501-516
53. Awad IA, Carter LP, Spetzler RF, et al. Clinical vasospasm after subarachnoid hemorrhage: Response to hypervolemic hemodilution and arterial hypertension. Stroke 1987; 18 (2): 365-372
54. Kassell NF, Peerless SJ, Durward QJ, et al. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982; 11 (3): 337-343
55. Origitano TC, Wascher TM, Reichman OH, et al. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage. Neurosurgery 1990; 27 (5): 729-739
56. Corsten L, Raja A, Guppy K, et al. Contemporary management of subarachnoid hemorrhage and vasospasm: The UIC experience. Surg Neurol 2001; 56 (3): 140-148 (Pubitemid 32946842)
57. Klimo P, Jr, Kestle JR, MacDonald JD, et al. Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 2004; 100 (2): 215-224